2438. Ceftolozane/Tazobactam (C/T) Against Multidrug-Resistant Pseudomonas aeruginosa (MDR-Pa) Infections: Clinical Efficacy, and Baseline and Emergent Resistance

BACKGROUND: Experience is mounting for C/T against MDR-Pa infections. More data are needed on efficacy for different infections, and baseline and emergent resistance. METHODS: We retrospectively reviewed patients receiving >48 hours of C/T for MDR-Pa infections. Clinical success was defined at 30...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Ryan K, Haidar, Ghady, Potoski, Brian A, Doi, Yohei, Marini, Rachel V, Nguyen, M Hong, Clancy, Cornelius J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255415/
http://dx.doi.org/10.1093/ofid/ofy210.2091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255415/
http://dx.doi.org/10.1093/ofid/ofy210.2091

Ejemplares similares